Current Meetings


October 2011 Meeting

"Innovative Technologies for HPLC, GC, and Sample Prep"


CSSC is pleased to announce the October 2011 CSSC meeting will be held together with Supleco seminar at the Four Points by Sheraton Meriden, Meriden CT.  The meeting will feature five technical presentations sponsored by Supleco and CSSC, as well as lunch and dinner.

Registration deadline is Wednesday, October 19, 2011.

To use the online system, you must be registered as a user.
Click here to become a registered user.


Date:

Wednesday, October 19, 2011

Location:

Four Points by Sheraton Meriden
Meriden, CT

Speakers:

Dr. Hillel Brandes, Supelco  
Dr. Zachary S. Breitbach,University of Texas at Arlington               Dr. Shengli Ma, Boehringer Ingelheim Pharmaceuticals, Inc.   Kimberly Navetta, Pfizer

Agenda:

12:00 (noon)  Registration and Lunch

1:15 - 2:40 pm HPLC, LC-MS and Sample Prep for LC: Techniques to  

                      Improve Speed, Resolution, and Sensitivity without        

                      Investing in Capital Equipment” Presented by Hillel

                      Brandes,Ph.D., Principle Applications Chemist, 

                      Supelco, Bellefonte, PA


2:45 - 3:40 pm “Advances in Macrocyclic Chiral Stationary Phases for

                       LC & SFC Enantiomeric Separations” and “Ionic

                       Liquids in GC (Including Rapid Water Analyses) and

                       the Ultra-Sensitive ESI-MS of Anions” Presented by

                       Zachary S. Breitbach, Ph.D., University of Texas at

                       Arlington, Arlington, TX

 

3:45 - 4:30 pm Mechanism of Enantioseparation on Macrocyclic

                       Glycopeptide Chiral HPLC & CE Phases” Presented by

                       Shengli Ma, Ph.D., Boehringer Ingelheim

                       Pharmaceuticals, Inc., Ridgefield, CT

 

4:35 - 5:00 pmSolid Phase Microextraction (SPME): Technology

                       Overview and Recent Advances using SPME in

                       Bioanalysis” Presented by Hillel Brandes

 

5:15 – 6:00 pmTransfer of Biomarker Assays from RIA and ELISA to

                        LC/MS/MS” Presented by Kimberly Navetta, Pfizer,

                        Groton Laboratories, Discovery Safety Evaluation, 

                        Groton, CT

 

6:00 PM. Complimentary dinner provided by the Connecticut Separation Science Council (CSSC).

 

 

Cost:

Free—You must Register at one of the sites below

Registration:

To Register, for the Half day session, Visit the Sigma-Aldrich Website  www.sigma-aldrich.com/analytical-seminars

 

To register ONLY for the dinner meeting (with Technical presentation beginning at 5:15 pm) visit the CSSC Site: http://www.cssconline.org/Meetings/Current_Meetings.asp

Abstract     Biography      Directions     Register

Home     Current Meetings     Past Meetings


Abstract:  

LC, LC-MS and Sample Prep for LC: Techniques to Improve Speed, Resolution, and Sensitivity without Investing in Capital Equipment

This talk describes recent innovations in particles, sorbents, surface chemistries, column/device formats, and reagents for HPLC and sample prep that address the need for higher throughput, better sensitivity, and greater resolution. Intended to be instructional, the talk will explain the scientific principles behind today’s innovative technologies, such as Fused-Core particles, HybridSPE-Phospholipid technology for the low-level MS detection of small molecules in serum, solid phase microextraction (SPME), which has now been applied to bioanalysis, molecularly imprinted polymer SPE (SupelMIP), and others. Applications will be presented that demonstrate the utility of these innovations in pharma, food, forensics, environmental, bioanalysis, and other areas using interesting case studies based on the registrants’ areas of interest.

 

Part 1: Advances in Macrocyclic Chiral Stationary Phases for LC & SFC Enantiomeric Separations

Chiral macrocyclic molecules are one of the most important classes of chiral selectors known. They dominate GC and CE enantiomeric separations, as well as reversed phase and polar organic mode LC separations. This class of selectors will be briefly reviewed and the latest exciting results presented. The newest and most unique member of this family, cyclofructans, will be introduced. If time allows, new chiral stationary phases based on synthetic chiral polymers will be discussed as well.

Part 2: Ionic Liquids in GC (Including Rapid Water Analyses) and the Ultra-Sensitive ESI-MS of Anions

The first new class of GC stationary phases in 30 years are based on ionic liquids (ILs). They have unique selectivities, higher thermal and chemical stabilities than any of the known commercially available columns. We will describe them and their use in: the rapid, facile water analysis of virtually any solvent and/or beverage, high temperature separations, FAME isomer separations, separations with an air carrier gas, GC x GC, and other applications. ILs with multifunctional cations also can be used as a trace additive for the ultra sensitive detection of anions in the positive mode of ESI-MS. The mechanism and use of this novel technique will be described for both organic and inorganic anions.

 

Mechanism of Enantioseparation on Macrocyclic Glycopeptide Chiral HPLC and CE Phases

Macrocyclic glycopeptides are a class of compounds often used for separation of enantiomers via either HPLC or CZE. Two such macrocyclic glycopeptides are teicoplanin and teicoplanin aglycone, and our work focused on their chromatographic behavior. These compounds are immobilized on silica matrixes and are commercially available under the trade names Astec CHIROBIOTIC T2 and TAG, respectively. The separation of propranolol was performed on both chiral stationary phases. A reversal of elution order was obtained when the compound was separated on CHIROBIOTIC T2, compared with TAG. In order to understand this behavior, vibrational circular dichroism was undertaken in different solvents and at different temperature. The presentation will describe all the changes occurring

with these two macrocycles under the experimental conditions.

 

Solid Phase Microextraction (SPME): Technology Overview and Recent Advances using SPME in Bioanalysis

This talk will describe a new Solid Phase Microextraction (SPME) fiber probe that permits the extraction of small molecule analytes directly from biological fluids and other complex matrixes. It comprises a metal-based fiber core coated with mixed-mode HPLC particles (C18/SCX) embedded in a proprietary biocompatible binder. Large macromolecules, such as proteins and glycolipids, are repelled, while smaller analytes, such as drugs and metabolites, bind to the particles and are extracted. Because SPME is concentration dependent rather than volume dependent, sample volumes down to 100 μL can be extracted and desorbed with as little as 50 μL. This is an advantage with precious samples, like plasma from neonates, transgenic mice, and other small mammals. The device is compatible

with common laboratory robotics equipment, and allows simultaneous extraction or desorption of multiple samples for high throughput sample prep.

 

Transfer of Biomarker Assays from RIA and ELISA to LC/MS/MS

The Biomarkers’ Laboratories at Pfizer have initiated the replacement of some ELISA and RIA kits for small molecule biomarkers with mass spectrometry (MS) assays. When a direct comparison was conducted, the MS assays demonstrated three major benefits over the kits: lower costs, shorter delivery times, and higher levels of specificity. For example, the MS assay for aldosterone costs ten times less and data reports are generated 2 days faster. Corticosterone was moved to the MS assay not only for the cost savings, but the reduction in sample volume requirements. When evaluating the specificity of the kits for small molecules, many antibodies used cross-reacted with molecules of similar structures, potentially providing false readings. To date, three MS assays have been deployed to portfolio programs in place of their respective kits (corticosterone, aldosterone and 25-OH Vitamin D3), and other assays are being evaluated for future deployment. As MS is becoming established in the clinical setting, this platform is broadening its impact in clinical pathology applications, enhancing drug development. These changes not only provide substantial cost and time savings, but they provide higher quality data for project teams..

 

 

Complete details of the event can also be found at www.sigma-aldrich.com/analytical-seminars


Directions: Click Here for Directions

Four Points by Sheraton Meriden
275 Research Parkway
Meriden, CT 06450

Phone: (203) 238-2380

Last Updated:  09/23/2011 01:10 PM


Return to Information Page

  

CSSC Home   

Copyright 2002-2010 -- All Rights Reserved